AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $270,504 | +55.3% | 600,455 | 0.0% | 0.00% | – |
Q1 2023 | $174,131 | +64393.0% | 600,455 | 0.0% | 0.00% | – |
Q4 2022 | $270 | -99.9% | 600,455 | +52.4% | 0.00% | – |
Q3 2022 | $207,000 | +4.0% | 394,020 | 0.0% | 0.00% | – |
Q2 2022 | $199,000 | -87.5% | 394,020 | -43.1% | 0.00% | – |
Q1 2022 | $1,592,000 | -51.1% | 692,221 | +0.9% | 0.00% | – |
Q4 2021 | $3,257,000 | -40.6% | 685,745 | -0.6% | 0.00% | -100.0% |
Q3 2021 | $5,485,000 | +16.3% | 689,997 | +1.8% | 0.00% | 0.0% |
Q2 2021 | $4,716,000 | -9.5% | 677,726 | +3.0% | 0.00% | 0.0% |
Q1 2021 | $5,210,000 | +16.8% | 657,870 | +16.0% | 0.00% | 0.0% |
Q4 2020 | $4,462,000 | +10.7% | 567,013 | -0.3% | 0.00% | 0.0% |
Q3 2020 | $4,030,000 | -25.2% | 568,458 | -2.4% | 0.00% | 0.0% |
Q2 2020 | $5,389,000 | +262.7% | 582,644 | +82.6% | 0.00% | – |
Q1 2020 | $1,486,000 | -68.9% | 319,080 | -49.1% | 0.00% | -100.0% |
Q4 2019 | $4,784,000 | +99.1% | 626,342 | +100.4% | 0.00% | 0.0% |
Q3 2019 | $2,403,000 | +17.3% | 312,487 | +4.5% | 0.00% | – |
Q2 2019 | $2,048,000 | +5.7% | 299,081 | +24.2% | 0.00% | -100.0% |
Q1 2019 | $1,937,000 | -20.4% | 240,736 | -26.0% | 0.00% | – |
Q4 2018 | $2,434,000 | +64.9% | 325,194 | +110.8% | 0.00% | – |
Q3 2018 | $1,476,000 | -5.3% | 154,287 | +4.7% | 0.00% | – |
Q2 2018 | $1,559,000 | +412.8% | 147,404 | +380.9% | 0.00% | – |
Q1 2018 | $304,000 | +84.2% | 30,649 | 0.0% | 0.00% | – |
Q4 2017 | $165,000 | +13.8% | 30,649 | 0.0% | 0.00% | – |
Q3 2017 | $145,000 | +23.9% | 30,649 | 0.0% | 0.00% | – |
Q2 2017 | $117,000 | -52.4% | 30,649 | -7.5% | 0.00% | – |
Q1 2017 | $246,000 | +143.6% | 33,142 | +42.2% | 0.00% | – |
Q4 2016 | $101,000 | -17.9% | 23,311 | +21.3% | 0.00% | – |
Q3 2016 | $123,000 | – | 19,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |